RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
ConvaTec Group - Stock

ConvaTec Group Stocks 2024

ConvaTec Group Stocks

2.05 B

Ticker

CTEC.L

ISIN

GB00BD3VFW73

WKN

A2AUD3

In 2024, ConvaTec Group had 2.05 B outstanding stocks, a 0% change from the 2.05 B stocks in the previous year.

The ConvaTec Group Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2029e2.05
2028e2.05
2027e2.05
2026e2.05
2025e2.05
2024e2.05
20232.05
20222.04
20212.03
20202.01
20191.98
20181.96
20171.95
20161.38
20151.95
20141.95
20131.95

ConvaTec Group shares outstanding

The number of shares was ConvaTec Group in 2023 — This indicates how many shares 2.053 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue ConvaTec Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates ConvaTec Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of ConvaTec Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating ConvaTec Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

ConvaTec Group Aktienanalyse

What does ConvaTec Group do?

ConvaTec Group is a global leading company specialized in the development and manufacturing of medical products and technologies for chronic diseases and wounds. The company was founded in the UK in 1978 and has since established a strong presence in over 100 markets worldwide. Over time, ConvaTec has become a significant leader in the healthcare industry. The company was originally founded by doctors to develop better therapies for patients with chronic diseases and wounds. It started with the development of skincare products for individuals with impaired skin barrier, such as patients with stoma and incontinence. Today, ConvaTec offers a variety of products and therapies for chronic diseases and wounds. ConvaTec operates its business in multiple product segments, each offering unique products and services. These segments include Advanced Wound Care, Infusion Devices, Stoma Care, and Continence and Critical Care. As a company, ConvaTec places a strong emphasis on innovation and research to continuously improve products and meet new medical needs. Collaborating closely with physicians, nursing staff, and patients is also emphasized. ConvaTec offers a comprehensive product portfolio. Advanced Wound Care includes a wide range of wound care products, including hydrocolloid dressings, foam dressings, and other biological collagen products. Infusion Devices consist of pump systems and catheters for administering fluids, medications, and nutrients over an extended period. Stoma Care produces products that support patients with an artificial opening to continue their daily lives as normally as possible. Continence and Critical Care provide solutions for bladder and bowel management of patients in critical situations, such as intensive care units. ConvaTec has become a leading company in the field of medical products and technologies over the years, thanks to its innovative products and a consistent focus on meeting people's needs. Through the use of new technologies and a strong focus on user feedback, ConvaTec has contributed to improving the lives of patients worldwide. Output: ConvaTec Group is a global leading company specialized in the development and manufacturing of medical products and technologies for chronic diseases and wounds. ConvaTec Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating ConvaTec Group's Shares Outstanding

ConvaTec Group's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in ConvaTec Group’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding ConvaTec Group’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in ConvaTec Group’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about ConvaTec Group Stock

How many stocks are there of ConvaTec Group?

The current number of stocks of ConvaTec Group is 2.05 B undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of ConvaTec Group are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of ConvaTec Group evolved in recent years?

The number of shares of ConvaTec Group has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. ConvaTec Group as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of ConvaTec Group?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does ConvaTec Group pay?

Over the past 12 months, ConvaTec Group paid a dividend of 0.05 USD . This corresponds to a dividend yield of about 1.7 %. For the coming 12 months, ConvaTec Group is expected to pay a dividend of 0.05 USD.

What is the dividend yield of ConvaTec Group?

The current dividend yield of ConvaTec Group is 1.7 %.

When does ConvaTec Group pay dividends?

ConvaTec Group pays a quarterly dividend. This is distributed in the months of September, May, September, May.

How secure is the dividend of ConvaTec Group?

ConvaTec Group paid dividends every year for the past 0 years.

What is the dividend of ConvaTec Group?

For the upcoming 12 months, dividends amounting to 0.05 USD are expected. This corresponds to a dividend yield of 1.68 %.

In which sector is ConvaTec Group located?

ConvaTec Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von ConvaTec Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ConvaTec Group from 5/23/2024 amounting to 0.035 USD, you needed to have the stock in your portfolio before the ex-date on 4/25/2024.

When did ConvaTec Group pay the last dividend?

The last dividend was paid out on 5/23/2024.

What was the dividend of ConvaTec Group in the year 2023?

In the year 2023, ConvaTec Group distributed 0.046 USD as dividends.

In which currency does ConvaTec Group pay out the dividend?

The dividends of ConvaTec Group are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von ConvaTec Group

Our stock analysis for ConvaTec Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ConvaTec Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.